2012-09-18 07:54:12 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Other Respiratory Disorders - Pipeline Review, H2 2012', provides an overview of the Other Respiratory Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Respiratory Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Respiratory Disorders. 'Other Respiratory Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.


Full Report Details at
- www.fastmr.com/prod/463760_other_respiratory_disorders_pipeline_ ..


Scope

* A snapshot of the global therapeutic scenario for Other Respiratory Disorders.
* A review of the Other Respiratory Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Other Respiratory Disorders pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Other Respiratory Disorders.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Other Respiratory Disorders pipeline depth and focus of Other Respiratory Disorders therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Other Respiratory Disorders Therapeutic Products under Development, Key Players in Other Respiratory Disorders Therapeutics, Other Respiratory Disorders Pipeline Overview, Other Respiratory Disorders Pipeline, Other Respiratory Disorders Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Other Respiratory Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Other Respiratory Disorders
Other Respiratory Disorders Therapeutics under Development by Companies
Other Respiratory Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Other Respiratory Disorders Therapeutics - Products under Development by Companies
Other Respiratory Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Other Respiratory Disorders Therapeutics Development
Pharmaxis Ltd.
Other Respiratory Disorders - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Bronchitol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Enbrel + Methylprednisolone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ribavirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Leukine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Baclofen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Inositol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Virazole (Ribavirin) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Other Respiratory Disorders Therapeutics - Drug Profile Updates
Other Respiratory Disorders Therapeutics - Discontinued Products
Other Respiratory Disorders Therapeutics - Dormant Products
Other Respiratory Disorders - Product Development Milestones
Featured News & Press Releases
Jun 27, 2012: Researchers Provide Further Rationale For Proteo's Elafin Treatment In Newborn Infants
Mar 13, 2012: Cortex Reports Issuance Of Patents For Next Generation Of Ampakine Compounds
Mar 13, 2012: Cortex Obtains Patents For Next Generation Of Ampakine Compounds

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463760&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.